Sanofi top pharmaceuticals revenue change 2019

This statistic shows the change in revenue of Sanofi's top pharmaceuticals in 2019 compared to the previous year. Dupixent, a rare blood disorder drug, showed the highest growth rate among all of Sanofi's best-selling pharmaceutical drugs.

Change in revenue of Sanofi's top pharmaceuticals in 2019 compared to previous year*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2020

Region

Worldwide

Survey time period

2018 and 2019

Supplementary notes

* Change measured on a reported basis.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Amgen"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.